18 Sep 2024
// EXPRESSPHARMA
11 Sep 2024
// ECONOMICTIMES
09 Sep 2024
// ECONOMICTIMES
DATA COMPILATION
#PharmaFlow
Latest Content by PharmaCompass
KEY PRODUCTS
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #5C33
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Attending
26-28 November, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
Severity: Warning
Message: Undefined variable $tile1
Filename: tabs/exhibitions.php
Line Number: 43
Backtrace:
File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler
File: /var/www/html/application/models/CmnPec.php
Line: 1626
Function: view
File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create
File: /var/www/html/application/views/include/party/indexNew.php
Line: 86
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 1368
Function: include
File: /var/www/html/application/controllers/PharmaServices.php
Line: 4582
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #5C33
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Attending
26-28 November, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
Digital content 
CORPORATE CONTENT #SupplierSpotlight
NEWS #PharmaBuzz
18 Sep 2024
// EXPRESSPHARMA
https://www.expresspharma.in/strides-pharma-subsidiary-receives-usfda-approval-for-60-mg-fluoxetine-tablets/
11 Sep 2024
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-secures-shareholders-nod-for-onesource-specialty-cdmo-unit/articleshow/113257912.cms
09 Sep 2024
// ECONOMICTIMES
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/proxy-advisors-vote-against-strides-pharmas-consolidation-scheme/113185732?utm_source=top_news&utm_medium=sectionListing
07 Sep 2024
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-gets-usfda-nod-for-theophylline-extended-release-tablets/articleshow/113115295.cms
05 Sep 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215312
19 Aug 2024
// PRESS RELEASE
https://www.strides.com/pdf/pressrelease/2024/StridesSEIntimation_19_Aug_24.pdf
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ABACAVIR SULFATE
Dosage Strength : EQ 300MG BASE
Packaging :
Approval Date : 2016-10-28
Application Number : 91050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 25MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 100MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACARBOSE
Dosage Strength : 50MG
Packaging :
Approval Date : 2011-07-27
Application Number : 90912
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2003-08-27
Application Number : 40511
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2020-09-21
Application Number : 203647
Regulatory Info : RX
Registration Country : USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABACAVIR SULFATE
Dosage Strength : EQ 300MG BASE
Approval Date : 2016-10-28
Application Number : 91050
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ACARBOSE
Dosage Strength : 25MG
Approval Date : 2011-07-27
Application Number : 90912
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ACARBOSE
Dosage Strength : 50MG
Approval Date : 2011-07-27
Application Number : 90912
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ACARBOSE
Dosage Strength : 100MG
Approval Date : 2011-07-27
Application Number : 90912
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET; ORAL
Proprietary Name : BUTALBITAL, ACETAMINOPHE...
Dosage Strength : 325MG;50MG;40MG
Approval Date : 2003-08-27
Application Number : 40511
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : TABLET; ORAL
Proprietary Name : BUTALBITAL, ACETAMINOPHE...
Dosage Strength : 325MG;50MG;40MG
Approval Date : 2020-09-21
Application Number : 203647
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AB
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : BUTALBITAL, ACETAMINOPHE...
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 2020-07-08
Application Number : 204649
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAMINOPHEN AND CODEIN...
Dosage Strength : 300MG;30MG
Approval Date : 1988-09-30
Application Number : 89805
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAMINOPHEN AND CODEIN...
Dosage Strength : 300MG;60MG
Approval Date : 1988-09-30
Application Number : 89828
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code : AA
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAMINOPHEN AND CODEIN...
Dosage Strength : 300MG;15MG
Approval Date : 1988-09-30
Application Number : 89990
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KEY PRODUCTS
TOP RANKED SUPPLIER FOR:
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
